Abbott Faces FDA Scrutiny On FreeStyle Libre And Broader Quality Story

Abbott Laboratories (NYSE:ABT) received an FDA warning letter focused on the accuracy and testing of its FreeStyle Libre ...

Abbott’s Exact Sciences Deal Recasts Diagnostics While Nutrition Faces Reset

Abbott Laboratories (NYSE:ABT) agreed to acquire Exact Sciences for US$21b. The deal is set to reshape Abbott's diagnostics business by adding a broad cancer testing platform. Management is also ...
Modesto Bee

Abbott’s fast coronavirus test could pose safety issue for those processing results

Lab personnel say worries are mounting over the safety of a rapid coronavirus test by Abbott Laboratories that President Donald Trump has repeatedly lauded ― particularly, the risk of infection to ...
Kalkine Media

Abbott Laboratories (NYSE:ABT) Finds Support After Recent S&P 500 Decline

Abbott Laboratories (NYSE:ABT) operates in the healthcare sector, where results can shift with product-cycle timing, ...
Chicago Tribune

Abbott’s COVID-19 test sales dive by nearly 90%

Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on ...

Abbott Laboratories Earnings Call: Devices Offset Nutrition Drag

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.